STIM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally...

Stats
Today's Volume	21 017.00
Average Volume	172 583
Market Cap	111.59M
EPS	$0 ( 2024-03-05 )
Next earnings date	( $-0.330 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.57
ATR14	$0.0190 (0.50%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Macan William Andrew	Buy	15 000	Common Stock
2024-02-28	Macan William Andrew	Sell	22 377	Common Stock
2024-02-29	Macan William Andrew	Sell	6 026	Common Stock
2024-02-29	Furlong Stephen	Buy	15 000	Common Stock
2024-02-27	Furlong Stephen	Sell	21 272	Common Stock

INSIDER POWER
17.37
Last 100 transactions
Buy: 1 892 506 \| Sell: 1 430 741

Volume Correlation

Long: 0.09 (neutral)

Short: -0.58 (weak negative)

Signal:(57.522) Neutral

Neuronetics Inc Correlation

10 Most Positive Correlations
AMRB	0.956
MDRX	0.913
FGFPP	0.908
NETE	0.908
MMAC	0.907
LWAC	0.901
XEL	0.897
UTHR	0.888
LNT	0.885
RVSB	0.884

10 Most Negative Correlations
SVAC	-0.929
PAYO	-0.904
TLGT	-0.902
PRVA	-0.886
PAIC	-0.885
MRUS	-0.88
WAVD	-0.875
MTSL	-0.868
XPER	-0.868
RMRM	-0.866

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neuronetics Inc Correlation - Currency/Commodity

0.52
( weak )

0.51
( weak )

0.00
( neutral )

0.29
( neutral )

-0.43
( neutral )

0.45
( neutral )

Neuronetics Inc Financials

Annual	2023
Revenue:	$71.35M
Gross Profit:	$49.70M (69.66 %)
EPS:	$-1.050

Q4	2023
Revenue:	$20.31M
Gross Profit:	$15.27M (75.16 %)
EPS:	$-0.190

Q3	2023
Revenue:	$17.88M
Gross Profit:	$11.76M (65.78 %)
EPS:	$-0.330

Q2	2023
Revenue:	$17.61M
Gross Profit:	$12.77M (72.54 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Neuronetics Inc

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.